20VC: Lessons from Jensen Huang on "Founder Mode" | How to Know if OpenAI or Anthropic Will Kill your Company | How USV Liking Music Made Them $1BN on an Investment | The Five Year Desert to Product Market Fit & a $5.3BN Valuation with Shiv Rao @ Abridge

Shiv Rao built Abridge around the idea that clinical conversations form the foundational signal in healthcare. After a five-year period of limited traction following the 2018 founding, the company reached a $5.3 billion valuation by focusing on persistent execution rather than frequent pivots of the core premise. Rao describes decisions around market timing, product architecture, model development, and internal culture that shaped how the company moved from early experiments to enterprise-scale deployment.

Holding the Thesis Through Timing Uncertainty

Rao maintained a fixed view that conversations between clinicians and patients contain the highest-value unstructured data in care delivery. He allowed flexibility on product features, go-to-market sequencing, and even business models, but treated the underlying thesis as non-negotiable. This stance required accepting extended periods of low validation while waiting for both model capabilities and buyer readiness to align. Rao notes that healthcare demand pressures, including clinician burnout after the pandemic and ongoing reimbursement constraints, eventually created the opening. The same rigidity on thesis combined with adaptability elsewhere allowed the company to shift from an initial consumer-facing product to enterprise workflows once the market inflection occurred.

Taste and Judgment as Operating Constraints